sars cov 2 — grants

Sort

8,912 grants matching “sars cov 2”

Inducible HMGB1 antagonist for viral-induced acute lung injury.

$62,894

Jorge C Blanco · Sigmovir Biosystems, Inc. · R41 · FY2024 · HL

Epigenetic modifiers of regulatory T cell function following viral pneumonia

$62,868

Benjamin David Singer · Northwestern University At Chicago · R01 · FY2021 · HL

Extending a digital risk mitigation intervention for workers deployed in diverse post-flood environments to address unique SAR-CoV-2 virus infection exposure risks in construction workplaces

$62,559

Jeffery McLaughlin · Radiant Creative Group, Llc · R43 · FY2020 · ES

Development of Metagenomic RNA-Seq Standard Operating Procedure for Variant-agnostic Whole Genome Sequencing of SARS-CoV-2 isolates from Animal Samples

$62,531

Zhenyu Shen · University Of Missouri-Columbia · U18 · FY2023 · FD

Role of macrophages in CBD mediated attenuation of SEB-induced ARDS

$62,501

Kiesha Wilson · University Of South Carolina At Columbia · K99 · FY2023 · GM

Michigan Center for Diabetes Translational Research

$62,400

Mary Ellen Michele Heisler · University Of Michigan At Ann Arbor · P30 · FY2022 · DK

Development of antibodies to specific cell surface markers to assess macrophage polarization during Adenovirus 14 and 14p1 infection in the Syrian hamster

$62,300

Jay R Radke · Idaho Veterans Research / Education Fdn · R03 · FY2024 · AI

Development of antibodies to specific cell surface markers to assess macrophage polarization during Adenovirus 14 and 14p1 infection in the Syrian hamster

$62,300

Jay R Radke · Idaho Veterans Research / Education Fdn · R03 · FY2023 · AI

Role of Cardiac Dysfunction and Injury in High-Risk Acute Respiratory Distress Syndrome Subphenotypes

$61,416

Pablo Sanchez · Stanford University · F32 · FY2022 · HL

tissue tropism of coronavirus

$61,323

Yasmine Belkaid · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI

SARS-CoV2 Sequencing Surveillance Program for Upstate South Carolina

$61,179

Hai Yao · Clemson University · P20 · FY2022 · GM

COVID supplement: A multi-site study seeking to study immune responses developed after infection with SARS-CoV-2

$61,062

Ted Ross · University Of Georgia · N01 · FY2022 · AI

Surveillance genome sequencing to detect SARS-CoV-2 virus variants in Montana

$60,976

Bruce E Bowler · University Of Montana · P30 · FY2022 · GM

Vaccine Response and Immunotherapeutics SWG

$60,809

Anna Palmer Durbin · Johns Hopkins University · P30 · FY2022 · AI

Great Plains IDeA-Clinical and Translational Research Network, Urgent Competitive Revisions to IDeA and NARCH Programs for SARS-CoV-2 Surveillance Studies

$60,285

Matthew Rizzo · University Of Nebraska Medical Center · U54 · FY2022 · GM

Implementation of a liquid handler that can increase capacity of SARS-CoV-2 sequencing in animals with COVID-19.

$60,154

Brianna Stenger · North Dakota State University · U18 · FY2023 · FD

Hospital-Associated Respiratory Virus Infections: Molecular Epidemiology, Clinical Outcomes, and Cost-Effectiveness of Interventions - COVID-19 Administrative Supplement

$60,002

Joshua Glenn Petrie · University Of Michigan At Ann Arbor · K01 · FY2021 · AI

Increasing the diagnostic PCR and next-generation sequencing capacity for the diagnosis and variant detection of COVID-19 in animals at the North Dakota State University Veterinary Diagnostic Lab

$59,941

Brianna Stenger · North Dakota State University · U18 · FY2021 · FD

RAPID: Collaborative Research: Bat goblet cells as immuno-hotspots for infection of coronavirus

$59,204

Liliana M Davalos · Suny At Stony Brook · · FY2020 · BIO

Repurposing of ABL kinase inhibitors for treatment of Coronavirus infections

$59,166

Jeanne Sisk · Johns Hopkins University · F32 · FY2017 · AI

Nurses Health Study 3: A multiple exposure environmental epidemiology cohort of young adults

$59,015

Francine Laden · Harvard School Of Public Health · R24 · FY2021 · ES

Inducible HMGB1 antagonist for viral-induced acute lung injury.

Epigenetic modifiers of regulatory T cell function following viral pneumonia

Extending a digital risk mitigation intervention for workers deployed in diverse post-flood environments to address unique SAR-CoV-2 virus infection exposure risks in construction workplaces

Development of Metagenomic RNA-Seq Standard Operating Procedure for Variant-agnostic Whole Genome Sequencing of SARS-CoV-2 isolates from Animal Samples

Role of macrophages in CBD mediated attenuation of SEB-induced ARDS

Michigan Center for Diabetes Translational Research

Development of antibodies to specific cell surface markers to assess macrophage polarization during Adenovirus 14 and 14p1 infection in the Syrian hamster

Development of antibodies to specific cell surface markers to assess macrophage polarization during Adenovirus 14 and 14p1 infection in the Syrian hamster

COVID-19: 3D Bioprinted Tissue Models for Respiratory Viruses

Viral and immune-mediated CNS pathology during SARS-CoV-2 infection

Development of COVID-19 cell entry inhibitors

Patterns of immune response in COVID-19 patients

Role of Cardiac Dysfunction and Injury in High-Risk Acute Respiratory Distress Syndrome Subphenotypes

tissue tropism of coronavirus

SARS-CoV2 Sequencing Surveillance Program for Upstate South Carolina

COVID supplement: A multi-site study seeking to study immune responses developed after infection with SARS-CoV-2

Surveillance genome sequencing to detect SARS-CoV-2 virus variants in Montana

Vaccine Response and Immunotherapeutics SWG

Great Plains IDeA-Clinical and Translational Research Network, Urgent Competitive Revisions to IDeA and NARCH Programs for SARS-CoV-2 Surveillance Studies

Implementation of a liquid handler that can increase capacity of SARS-CoV-2 sequencing in animals with COVID-19.

Hospital-Associated Respiratory Virus Infections: Molecular Epidemiology, Clinical Outcomes, and Cost-Effectiveness of Interventions - COVID-19 Administrative Supplement

Increasing the diagnostic PCR and next-generation sequencing capacity for the diagnosis and variant detection of COVID-19 in animals at the North Dakota State University Veterinary Diagnostic Lab

RAPID: Collaborative Research: Bat goblet cells as immuno-hotspots for infection of coronavirus

Repurposing of ABL kinase inhibitors for treatment of Coronavirus infections

Nurses Health Study 3: A multiple exposure environmental epidemiology cohort of young adults